TrialJournal for immunotherapy of cancer2024

Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial.

Nikolai Kragøe Andresen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.